OXYGENTA PHARMACEUTICAL
Back to Cashflow Statement
|
OXYGENTA PHARMACEUTICAL Last 5 Year Net Cash Inflow / Outflow History
[Standalone]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Net Cash Inflow / Outflow | ₹0.02 Cr | ₹-0.01 Cr | ₹-0.05 Cr | ₹-0.29 Cr | ₹0.33 Cr |
What is the latest Net Cash Inflow / Outflow ratio of OXYGENTA PHARMACEUTICAL ?
| Year | Net Cash Inflow / Outflow |
|---|---|
| Mar2025 | ₹0.02 Cr |
| Mar2024 | ₹-0.01 Cr |
| Mar2023 | ₹-0.05 Cr |
| Mar2022 | ₹-0.29 Cr |
| Mar2021 | ₹0.33 Cr |
How is Net Cash Inflow / Outflow of OXYGENTA PHARMACEUTICAL Trending?
| Years | Net Cash Inflow / Outflow | % Change | |
|---|---|---|---|
| Mar2025 | ₹0.02 Cr | Positive | |
| Mar2024 | ₹-0.01 Cr | Negative | |
| Mar2023 | ₹-0.05 Cr | Negative | |
| Mar2022 | ₹-0.29 Cr | Negative | |
| Mar2021 | ₹0.33 Cr | - | |
Compare Net Cash Inflow / Outflow of peers of OXYGENTA PHARMACEUTICAL
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| OXYGENTA PHARMACEUTICAL | ₹203.4 Cr | -0% | -8.4% | -40.2% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹424,982.0 Cr | -0.7% | -0.5% | -3.1% | Stock Analytics | |
| DIVIS LABORATORIES | ₹172,878.0 Cr | 2.8% | 2.2% | 10.8% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹129,095.0 Cr | 1.5% | 3.4% | 12.4% | Stock Analytics | |
| CIPLA | ₹122,175.0 Cr | 0.8% | 0.1% | 3.1% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹107,154.0 Cr | 0.4% | 3.2% | 0.3% | Stock Analytics | |
OXYGENTA PHARMACEUTICAL Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| OXYGENTA PHARMACEUTICAL | -0% |
-8.4% |
-40.2% |
| SENSEX | 0.4% |
-0.1% |
6.1% |
You may also like the below Video Courses